3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Agnosia
3
Prostatic Neoplasms
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Skin Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pituitary Diseases
1
Patient Satisfaction
1
Pain
1
Ovarian Neoplasms
1
Opioid Free Anesthesia
1
Neoplasms
1
Hypothalamic Neoplasms
1
Endometrial Neoplasms
1
Chronic Pain
1
Carcinoma, Squamous Cell
1
Carcinoma, Basal Cell
1
Breast Neoplasms
1
Bowen's Disease
1
Anxiety Disorders
1
Interventions
Cyclophosphamide
216
Methotrexate
140
Cytarabine
131
Vincristine
110
fludarabine phosphate
103
Peripheral Blood Stem Cell Transplantation
98
Filgrastim
92
Etoposide
92
Dexamethasone
89
Mycophenolic Acid
71
Doxorubicin
70
Whole-Body Irradiation
67
Mercaptopurine
66
Busulfan
65
Tacrolimus
64
Radiotherapy
63
Cyclosporine
62
Prednisone
55
Daunorubicin
53
pegaspargase
51
Asparaginase
51
Rituximab
48
fludarabine
47
Granulocyte Colony-Stimulating Factor
46
Melphalan
45
Antilymphocyte Serum
43
Clofarabine
42
Calcium Dobesilate
38
Methylprednisolone
36
Leucovorin
35
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Anesthesia, Local
×
Clear all
NCT04846855
2024-02-12
RATAPED
Ramsay Générale de Santé
Phase 4
Completed
100 enrolled